-
Chronic insomnia in older adults improved more with objective measures when treated with cognitive behavioral therapy rather than nightly medications.
-
The FDA has given an accelerated approval for a new protease inhibitor (PI) for the treatment of HIV infections. Darunavir (TMC114) is approved for patients who have shown resistance to more than one protease inhibitor.
-
The two non-sequential lead II rhythm strips shown in the image were interpreted as showing "sinus tachycardia (top strip) with sudden development of PSVT" (lower strip).
-
Cephalosporins should be considered for penicillin-allergic patients due to low cross-reactivity risk, but these patients do have a small increased risk of subsequent reactions to both sulfonamides and cephalosporins.
-
Black cohosh, when studied in appropriate randomized trials, is no different than placebo treatment in affecting hot flushing.
-
Borrelia persica is the causative agent of tick-borne relapsing fever (TBRF). The Borrelia name will be familiar to clinicians because of Lyme disease, caused by Borrelia burgdorferi.
-
Do long-acting beta agonist inhalers increase the severity of asthma? Yes, according to the results from a large meta-analysis recently published in the Annals of Internal Medicine.
-
The CDC received reports of 1324 patients with malaria in the United States and its territories diagnosed in 2004; 4 patients died. This represented a 3.6% increase in cases from the previous year. US civilians accounted for 58.5% of cases.
-
In recent years, S. aureus has been identified as the most common cause of infective endocarditis (IE). Risk factors for S. aureus IE include the presence of indwelling prosthetic devices and intravascular catheters.
-
